CIENCIASMEDICASNEWS: Prostate cancer on the rise and detected late in the UK finds report

jueves, 3 de mayo de 2018

Prostate cancer on the rise and detected late in the UK finds report

	May 3, 2018
	Prostate Cancer
	The latest prostate cancer news from News Medical

Prostate cancer on the rise and detected late in the UK finds report

As many as 37 percent of all prostate cancers are detected late or in advanced stages in the UK, finds a new report from the charity Orchid. The report suggests that most of these cancers are detected at stages 3 and 4. Statistics show that nearly 47,000 men are diagnosed with prostate cancer annually and 11,000 succumb to the disease each year.

			Shorter courses of radiotherapy found to be safe, effective for prostate cancer patients Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients, according to research presented at the ESTRO 37 conference today.

			Researchers develop better method to identify areas with highest prostate cancer burden To catch prostate cancer at earlier stages, when it's more easily treated, many institutions do community outreach and education sessions to explain why cancer screenings can be life-saving. In order to have the highest impact, however, institutions must select where to focus their efforts.

	New web-based support program could help reduce psychological stress in prostate cancer survivors A new web-based support programme will help reduce the psychological stress that impacts men who are recovering from prostate cancer.

	Study shows patients in major prostate cancer study are more likely to die than real-world patients Researchers at Henry Ford Hospital compared the patient population of a major U.S. prostate cancer study with patients found in three U.S. cancer databases, ultimately finding the patients of the study to be inconsistent with the average prostate cancer patient.

	Researchers find role of iron storage gene in slowing down prostate cancer growth An abnormally high level of iron in the body is associated with prostate cancer, and researchers from the Cancer Science Institute of Singapore at the National University of Singapore may have uncovered the mechanism to explain this link.

	Evolutionary history of tumor helps predict severity of prostate cancer Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumor has evolved. This information can be used to determine what type and how much treatment should be given to each patient, or if any is needed at all.

	Blue light exposure at night linked to higher risk of developing breast and prostate cancer A study performed by an international team led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, reports a link between exposure to blue light at night and higher risk of developing breast and prostate cancer.